Interestingly, HDAC inhibitors also possess the ability to inactivate other genes such as ARF1 which affects the EGFR degradation and the inhibition of HNSCC cells invasion [71]. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.